NextCure, Inc.

NXTC

NextCure, Inc.

NXTC

Insider Sentiment (TTM):

Last Purchase:2019-11-15Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,973,942Shares Outstanding:5,239,236Institutional Ownership Pct.:37.68%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	15	15	26	7	5	22	28	28	21	18	13	20
Debt Securities Available For Sale Excluding Accru…	5	15	16	22	30	34	41	48	66	78	95	99
Prepaid Expense And Other Assets Current	2	2	2	4	5	3	3	3	4	7	4	4
Assets Current	22	32	44	33	40	59	72	79	90	103	113	123
Property Plant And Equipment Net	0	3	3	4	4	5	5	6	7	7	9	10
Operating Lease Right Of Use Asset	-	2	3	3	3	3	3	3	4	4	4	5
Other Assets Noncurrent	0	1	1	1	1	0	0	2	2	2	2	3
Assets	23	38	50	40	48	67	81	90	103	115	128	140
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	3	3	2	2	3	3	5	4	5	4	2	3
Liabilities Current	6	7	11	11	11	6	10	9	11	10	7	7
Operating Lease Liability Noncurrent	4	4	4	4	5	5	5	5	6	6	6	6
Other Liabilities Noncurrent	0	0	1	1	1	1	1	1	1	1	1	1
Liabilities	10	11	15	16	16	11	15	15	17	16	14	13
Temporary Equity
Stockholders Equity
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	2	-	-	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	473	472	471	450	448	447	446	444	442	441	439	437
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	-0	-	0	0	-0	-0	-0	-1
Retained Earnings Accumulated Deficit	-461	-446	-436	-427	-418	-391	-380	-369	-357	-342	-324	-310
Stockholders Equity	12	27	35	24	30	56	65	76	85	99	114	126
Liabilities And Stockholders Equity	23	38	50	40	48	67	81	90	103	115	128	140
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	0.001	-	-	-	-	-	-	-
Temporary Equity Shares Authorized	-	-	-	-	100	-	-	-	-	-	-	-
Temporary Equity Shares Issued	-	-	-	-	0	-	-	-	-	-	-	-
Temporary Equity Shares Outstanding	-	-	-	-	0	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	4	4	4	3	2	2	2	2	2	2	2	2
Shares Outstanding	4	4	4	3	2	2	2	2	2	2	2	2

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-39.10%	-83.84%	-58.35%	-	-	-	-	-	-	-	-	-
2025	5.83%	-2.08%	-13.37%	-1.28%	11.87%	80.57%	46.31%	32.61%	23.78%	-21.55%	-17.55%	-38.64%
2024	4.03%	8.72%	13.42%	0.00%	-14.29%	-14.91%	-11.36%	-37.88%	-37.65%	-30.01%	-35.48%	-28.75%
2023	-	-	-	-	-	-	7.69%	-1.71%	-3.42%	14.29%	-1.79%	-17.26%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.47	4.61	4.14	2.97	3.71	10.26	7.50	9.07	8.35	10.70	16.38	18.72
Quick Ratio	3.13	4.32	3.96	2.65	3.28	9.73	7.17	8.68	7.98	10.02	15.73	18.04
Working Capital	15.84M	24.85M	33.18M	21.65M	29.23M	53.16M	62.23M	70.02M	79.62M	92.97M	105.84M	116.13M
Leverage & Debt
Debt to Equity	0.86	0.42	0.44	0.68	0.54	0.20	0.24	0.20	0.20	0.16	0.12	0.11
Debt Ratio	0.46	0.30	0.30	0.40	0.34	0.17	0.19	0.16	0.17	0.14	0.11	0.10
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-8.05	-10.43	-19.65	-21.68	-25.66	-21.22	-23.88	-25.10	-26.29	-27.42	-27.05	-28.27
Free Cash Flow Per Share TTM	-6.90	-9.54	-17.45	-13.45	-17.41	-17.87	-17.74	-19.31	-19.93	-22.12	-23.20	-22.82
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-29.84%	10.38%	0.34%	-0.87%	-0.57%	-22.30%	-11.27%	-10.74%	-12.67%	-9.25%	-16.07%	-11.85%
EPS Growth (1Y)	-68.62%	-50.83%	-17.73%	-13.64%	-2.40%	-22.62%	-11.71%	-11.20%	-13.15%	-9.66%	-16.35%	-12.14%
Valuation Metrics
P/E TTM	-0.20	-1.02	-0.72	-0.27	-0.22	-0.27	-0.39	-0.65	-0.73	-0.98	-0.51	-0.55
P/B TTM	0.70	2.09	1.15	0.66	0.44	0.24	0.33	0.51	0.52	0.63	0.28	0.28
Market Cap	8.50M	55.96M	40.33M	15.68M	13.11M	13.44M	21.56M	38.33M	44.48M	62.20M	31.72M	35.90M
Enterprise Value	-6.76M	40.79M	14.35M	8.36M	8.22M	-8.38M	-6.17M	10.63M	23.63M	43.84M	18.64M	16.38M
Calculated Values
Free Cash Flow TTM	-36.62M	-49.98M	-49.61M	-35.98M	-41.34M	-41.70M	-41.35M	-45.03M	-46.46M	-51.41M	-53.79M	-52.93M
Net Debt	-15.26M	-15.17M	-25.98M	-7.32M	-4.89M	-21.83M	-27.73M	-27.70M	-20.85M	-18.36M	-13.08M	-19.52M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2019-11-15Purchase

Owner: Sofinnova, Venture Partne…

Title: -

Shares: 150,000

Price/Share: $36.75

Value: $5,512,500.00

Shares Owned: 2,671,856

Relationship: TenPercentOwner

Ownership: Direct

2019-05-13Purchase

Owner: Sofinnova, Management Ix,…

Title: -

Shares: 400,000

Price/Share: $15.00

Value: $6,000,000.00

Shares Owned: 2,521,856

Relationship: TenPercentOwner

Ownership: Direct

2019-05-13Purchase

Owner: Canaan, X L.P., Canaan Pa…

Title: -

Shares: 50,000

Price/Share: $15.00

Value: $750,000.00

Shares Owned: 2,254,442

Relationship: TenPercentOwner

Ownership: Direct

2019-05-13Purchase

Owner: Orbimed, Capital Gp Vi Ll…

Title: -

Shares: 350,000

Price/Share: $15.00

Value: $5,250,000.00

Shares Owned: 2,711,013

Relationship: Director,TenPercentOwner

Ownership: Indirect

2019-05-13Purchase

Owner: Xu, Stella

Title: -

Shares: 125,000

Price/Share: $15.00

Value: $1,875,000.00

Shares Owned: 1,103,570

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2019-11-15	Sofinnova, Venture Partne…	TenPercentOwner	-	Direct	Purchase	150,000	36.75	$5,512,500.00	2,671,856	4
2019-05-13	Sofinnova, Management Ix,…	TenPercentOwner	-	Direct	Purchase	400,000	15.00	$6,000,000.00	2,521,856	4
2019-05-13	Canaan, X L.P., Canaan Pa…	TenPercentOwner	-	Direct	Purchase	50,000	15.00	$750,000.00	2,254,442	4
2019-05-13	Orbimed, Capital Gp Vi Ll…	Director,TenPercentOwner	-	Indirect	Purchase	350,000	15.00	$5,250,000.00	2,711,013	4
2019-05-13	Xu, Stella	Director	-	Indirect	Purchase	125,000	15.00	$1,875,000.00	1,103,570	4
2019-05-13	Khuong, Chau Quang	Director	-	Indirect	Purchase	350,000	15.00	$5,250,000.00	2,711,013	4
2019-05-13	Shannon, Timothy M	Director	-	Indirect	Purchase	50,000	15.00	$750,000.00	2,254,442	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

37.68%

Inst. Shares: 1,973,942

Shares Outstanding: 5,239,236

2025-12-31

65.82%

Inst. Shares: 1,870,823

Shares Outstanding: 2,842,448

2025-09-30

29.88%

Inst. Shares: 799,604

Shares Outstanding: 2,676,116

2025-06-30

35.05%

Inst. Shares: 832,280

Shares Outstanding: 2,374,729

2025-03-31

52.86%

Inst. Shares: 1,233,690

Shares Outstanding: 2,333,890

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,973,942	5,239,236	37.68%
2025-12-31	1,870,823	2,842,448	65.82%
2025-09-30	799,604	2,676,116	29.88%
2025-06-30	832,280	2,374,729	35.05%
2025-03-31	1,233,690	2,333,890	52.86%
2024-12-31	1,287,577	2,330,386	55.25%
2024-09-30	1,275,290	2,331,320	54.70%
2024-06-30	1,287,324	2,331,062	55.22%
2024-03-31	1,265,211	2,324,323	54.43%
2023-12-31	1,038,498	2,318,787	44.79%
2023-09-30	1,005,289	2,319,069	43.35%
2023-06-30	1,040,013	2,318,134	44.86%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

NextCure, Inc. (NXTC) — SEC Financial Statements & Analysis

NextCure, Inc. (NXTC) is a pharmaceutical preparations company, incorporated in DE. NextCure, Inc. trades on Nasdaq as: NXTC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), NextCure, Inc. reported a Debt-to-Equity ratio of 0.86x, a Price-to-Book (P/B) ratio of 0.70x (TTM), at a market cap of $8.50M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.86x
P/B TTM: 0.70x
Market Cap: $8.50M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NextCure, Inc. in?

NextCure, Inc. (NXTC) operates in the Pharmaceutical Preparations industry.

What is NXTC's market cap?

NextCure, Inc. (NXTC) has a market capitalization of $8.50M as of 2026-06-30.

What exchange does NXTC trade on?

NextCure, Inc. (NXTC) trades on the Nasdaq.

Where is NextCure, Inc. incorporated?

NextCure, Inc. is incorporated in DE.

NextCure, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

NextCure, Inc. (NXTC) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

NextCure, Inc. (NXTC) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.